|
CRP
|
ANG II
|
Leptin
|
Adiponectin
|
Resistin
|
TNF-α
|
aPAI
|
---|
All; Control; Cases
|
All; Control; Cases
|
All; Control; Cases
|
All; Control; Cases
|
All; Control; Cases
|
All; Control; Cases
|
All; Control; Cases
|
---|
Age (years)
| | | | | | | |
BMI (kg/m2)
|
0.38**; NS; 0.52**
| |
0.32**; NS; 0.44**
| | | | |
Systolic BP (mmHg)
| | | | | | |
NS; NS; 0.36*
|
Diastolic BP (mmHg)
| | | | | | |
0.25*; NS; NS
|
SAD (cm)
| | | | | | | |
Waist (cm)
|
0.44**; NS; 0.48**
| |
0.23*; NS; NS
|
−0.35**; NS; -0.45**
| | | |
Hips (cm)
|
NS; NS; 0.35*
| |
0.25*; NS; 0.44*
| | | | |
Glucose (mmol/l)
| | | |
NS; NS; -0.38*
| | |
0.28*; NS; NS
|
Total Cholesterol (mmol/l)
| | | | | | |
−0.28*; NS; NS
|
Triglycerides (mmol/l)
| | | |
−0.26*; NS; NS
| |
0.26*; NS; 0.28*
| |
HDL-Cholesterol (mmol/l)
| | | |
0.23*; NS; NS
| | | |
LDL-Cholesterol (mmol/l)
|
NS; 0.38*; NS
| | | | | |
−0.29**;-0.31*;
|
CRP (ug/ml)
| | |
0.26*; NS; 0.40*
|
−0.27*; -0.32*; NS
|
−0.26*; NS; -0.32*
| | |
ANG II (ng/ml)
| | | | | | |
NS; 0.48**; NS
|
Leptin (ng/ml)
|
0.26*; NS; 0.41*
| | | | |
0.23*; NS; NS
| |
Adiponectin (ug/ml)
|
−0.27*; NS; NS
| | |
NS; 0.28*; NS
| |
NS; 0.34*; NS
| |
Resistin (ng/ml)
|
−0.26*; NS; -0.32*
| | | | | |
NS; 0.45**; NS
|
TNF-α (pg/ml)
| | |
0.23*; 0.34*;
|
NS; NS; -0.38*
| | |
0.44**; 0.45**; 0.58**
|
aPAI (ng/ml)
| |
NS; 0.48*; NS
| |
NS; 0.37**; NS
| |
0.44**; 0.45**; 0.58**
| |
Ca (mmol/l)
| | | | | | |
−0.61**; NS; -0.75**
|
Pi (mmol/l)
| | | | |
0.36**; NS; NS
| | |
-
Note: Only significant associations were presented; Values presented as coefficient R; Coefficients presented from left to right [All, Control, Cases]; NS – Not Significant; * denotes significance at < 0.05 level; 88 denotes significance at < 0.001 level.